Literature DB >> 11208922

Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture.

M Maccarrone1, M Attinà, A Cartoni, M Bari, A Finazzi-Agrò.   

Abstract

Endocannabinoids are lipid mediators thought to modulate central and peripheral neural functions. We report here gas chromatography-electron impact mass spectrometry analysis of human brain, showing that lipid extracts contain anandamide and 2-arachidonoylglycerol (2-AG), the most active endocannabinoids known to date. Human brain also contained the endocannabinoid-like compounds N-oleoylethanolamine, N-palmitoylethanolamine and N-stearoylethanolamine. Anandamide and 2-AG (0.16 +/- 0.05 and 0.10 +/- 0.05 nmol/mg protein, respectively) represented 7.7% and 4.8% of total endocannabinoid-like compounds, respectively. N-Palmitoyethanolamine was the most abundant (50%), followed by N-oleoyl (23.6%) and N-stearoyl (13.9%) ethanolamines. A similar composition in endocannabinoid-like compounds was found in human neuroblastoma CHP100 and lymphoma U937 cells, and also in rat brain. Remarkably, human meningioma specimens showed an approximately six-fold smaller content of all N-acylethanolamines, but not of 2-AG, and a similar decrease was observed in a human glioblastoma. These ex vivo results fully support the purported roles of endocannabinoids in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208922     DOI: 10.1046/j.1471-4159.2001.00092.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  Levels of N-acylethanolamines in human tumors: in search of reliable data.

Authors:  Mauro Maccarrone; Filomena Fezza; Alessandro Finazzi-Agrò
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

Review 2.  [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].

Authors:  U Schneider; J Seifert; M Karst; J Schlimme; K Cimander; K R Müller-Vahl
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 3.  The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.

Authors:  Roger G Pertwee
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

Review 4.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  Insights into the effects of the endocannabinoid system in cancer: a review.

Authors:  Ana Isabel Fraguas-Sánchez; Cristina Martín-Sabroso; Ana Isabel Torres-Suárez
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

6.  Anandamide and other N-acylethanolamines in human tumors.

Authors:  Patricia C Schmid; Lester E Wold; Randy J Krebsbach; Evgueni V Berdyshev; Harald H O Schmid
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

7.  The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients.

Authors:  Mercedes Núñez; Sandra Perdomo; Juan Moreta; Ángel Santos-Briz; Rogelio González-Sarmiento
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

8.  An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain.

Authors:  Giulio G Muccioli; Nephi Stella
Journal:  Anal Biochem       Date:  2007-09-29       Impact factor: 3.365

9.  Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain.

Authors:  M Palkovits; J Harvey-White; J Liu; Z S Kovacs; M Bobest; G Lovas; A G Bagó; G Kunos
Journal:  Neuroscience       Date:  2008-02-05       Impact factor: 3.590

10.  Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.

Authors:  Stephen A Brose; Svetlana A Golovko; Mikhail Y Golovko
Journal:  Lipids       Date:  2016-03-28       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.